The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2015

Filed:

Mar. 18, 2011
Applicants:

Nobuyuki Ise, Tokyo, JP;

Daisuke Nambara, Tokyo, JP;

Kazuya Omi, Tokyo, JP;

Inventors:

Nobuyuki Ise, Tokyo, JP;

Daisuke Nambara, Tokyo, JP;

Kazuya Omi, Tokyo, JP;

Assignee:

FUJIREBIO INC., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/12 (2015.01); C07K 16/28 (2006.01); G01N 33/50 (2006.01); G01N 33/574 (2006.01); C12Q 1/48 (2006.01); G01N 33/566 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); C12Q 1/485 (2013.01); G01N 33/5011 (2013.01); G01N 33/566 (2013.01); G01N 33/574 (2013.01); G01N 33/57423 (2013.01); G01N 33/57492 (2013.01); G01N 2500/00 (2013.01); G01N 2800/44 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention enables to realize a convenient determination of a therapeutic effect of an anticancer agent on a cancer. Specifically, the present invention provides a diagnostic marker for an effect of an anticancer agent on a cancer, comprising a substance having an affinity for a fragment of an extracellular domain of c-MET; a diagnostic reagent for an effect of an anticancer agent on a cancer, comprising a substance having an affinity for a fragment of an extracellular domain of c-MET and the fragment of the extracellular domain of c-MET; and a method of testing an effect of an anticancer agent on a cancer, comprising (a) measuring a concentration of a fragment of an extracellular domain of c-MET in a biological sample from a subject, and (b) comparing the measured concentration of the fragment of the extracellular domain of c-MET with an indicator which presents a relationship between a concentration of the fragment of the extracellular domain of c-MET and the effect of the anticancer agent on the cancer.


Find Patent Forward Citations

Loading…